THURSDAY, MAY 23, 2013
Remember me:
Just Anticorruption
Companies > Pfizer Inc.
by Douglas Gillison | May 10th, 2013

After settling with the U.S. for $60 million, the company now faces a shareholder suit in New York saying its poor FCPA compliance damaged shareholder equity.

by Jeffrey Benzing | May 10th, 2013

As companies put a greater emphasis on compliance, the imposition of an outside monitor has become less common.

by Jennifer Koons | May 9th, 2013

Kerry Harvey, the U.S. Attorney for the Eastern District of Kentucky, announced the appointment of a new First Assistant and chief of the office’s civil division.

by Jeffrey Benzing | March 29th, 2013

Though companies now are required to admit to facts alleged by the Justice Department to settle parallel civil investigations, other similar conduct goes unacknowledged.

by Main Justice staff | March 14th, 2013

The DOJ’s FCPA unit chief discusses rogue employees, FCPA guidance, why even anonymized declinations will continue to be rarely disclosed, and the busy year facing prosecutors.

by Jeffrey Benzing | March 8th, 2013

The Justice Department’s Foreign Corrupt Practices Act unit chief spoke via telephone at the American Bar Association’s white collar crime conference in Las Vegas.

by Douglas Gillison | March 5th, 2013

The CEO, chairman of the board and chief compliance officer have all be removed as a result of a foreign bribery investigation involving shares in a former Taiwan subsidiary.

by Douglas Gillison | January 22nd, 2013

Three health care industry companies were among the biggest apparent beneficiaries of tax laws allowing deduction of disgorgement and pre-judgment interest, a Just Anti-Corruption analysis found.

by Jeffrey Benzing | January 3rd, 2013

The Justice Department and SEC secured roughly $260 million from FCPA settlements for the year.

by Douglas Gillison | December 20th, 2012

The company will pay almost $30 million to resolve allegations of bribery in China, Russia, Brazil and Poland.

by Jeffrey Benzing | November 8th, 2012

The government almost always links alleged foreign bribery conduct to the United States — but with U.S. companies, it doesn’t have to.

by Jeffrey Benzing | October 19th, 2012

Pharmaceutical giant Pfizer Inc., which settled a self-disclosed Foreign Corrupt Practices Act matter in August, has an open door policy regarding whistleblowers, in-house counsel Sarah Chopp told an American Bar Association conference in Washington, D.C.

by | October 1st, 2012

The SEC routinely scrubs its rolls of void and dissolved companies – actions that help the agency build its enforcement statistics.

by Douglas Gillison | September 14th, 2012

Advocates of Foreign Corrupt Practices Act reform returned to Capitol Hill on Friday to press their case, signalling that business interests haven’t given up on persuading Congress eventually to amend the statute despite recent adverse publicity over such foreign bribery cases as Wal-Mart Stores Inc.

by Jeffrey Benzing | August 7th, 2012

Agreement on the fine and disgorgement had reportedly been reached in November.

by Mary Jacoby | December 9th, 2011

Marc Smolonsky, associate deputy secretary at the Department of Health and Human Services, was among the panelists on Capitol Hill for the Main Justice forum: “What’s Next? Strategies for Improving Compliance with Fraud and Abuse Laws.”

by Mary Jacoby | November 20th, 2011

The industry-wide corruption probe, announced in a 2009 speech by DOJ Criminal Division chief Lanny Breuer, stemmed from internal investigations by Pfizer and rival Johnson & Johnson.

by Christopher M. Matthews | November 16th, 2011

The Justice Department and the Securities and Exchange Commission have been examining since 2004 whether the company violated the Foreign Corrupt Practices Act.

by Samuel Knight | October 25th, 2011

Michael Horowitz disclosed a multimillion dollar salary, multinational clients, and millions invested in mutual funds.

by Aruna Viswanatha | April 11th, 2011

A group of socially-conscious investors asked the companies to review their roles at the lobbying powerhouse. Just Anti-Corruption broke the story last month of the Chamber’s FCPA lobbying.

by Mary Jacoby | March 16th, 2011

Nancy Boswell is departing after “considerable reflection” and 17 often troubled years.

by Andrew Ramonas | March 9th, 2011

House Judiciary Committee Chairman Lamar Smith (R-Texas) said the House will offer its own patent reform bill.

by Aruna Viswanatha | February 28th, 2011

The investigation dates back to 2004, when the company began providing details to agencies about potential bribes in connection with sales overseas.

by Andrew Ramonas | February 18th, 2011

The Senate Judiciary Committee earlier this month backed the legislation without opposition.

by Andrew Ramonas | February 11th, 2011

The Senate Judiciary Committee last week approved its patent reform bill without opposition.

by Aruna Viswanatha | December 17th, 2010

Will a choice parking space be enough to keep employees from squealing to the Securities and Exchange Commission?

by David Stout | December 10th, 2010

The giant drug company categorically denies allegations in a leaked diplomatic cable.

by Aruna Viswanatha | November 22nd, 2010

The National Whistleblowers Center submitted a FOIA request to the Securities and Exchange Commission seeking documents on the agency’s meetings with corporate executives.

by Andrew Ramonas | November 22nd, 2010

The Justice Department only secured the recovery of more civil fraud claims in 2006.

by Mary Jacoby | November 3rd, 2010

The panel brought together three Washington, D.C.,-based former colleagues from the U.S. Department of Justice’s Criminal Fraud section: Steven Tyrrell, now a parter at Weil Gotshal & Manges LLP; Arnold & Porter LLP’s Kirk Ogrosky; and Patton Boggs LLP’s Jay Darden.

BEST FCPA LAWYERS PRACTICE GROUP OF THE YEAR. Main Justice held an awards luncheon in Washington, D.C., to honor top firms in the Foreign Corrupt Practices Act arena. This video shows announcement of the finalists and winner in the Practice Group of the Year category.

"Although Burke denied to congressional investigators that he had any retaliatory motive for his actions, we found substantial evidence to the contrary." -- OIG report faulting former U.S. Attorney Dennis Burke for giving a Fox News producer a memorandum about Fast and Furious case.